$MRCY

Mercury Systems (NASDAQ:MRCY) Director Howard Lance Sells 9,250 Shares

Mercury Systems director Howard Lance sold 9,250 shares on May 26 at an average price of $99.76, for about $922,780, according to an SEC filing. The stock traded around $97.11 midweek. Mercury reported May 5 quarterly EPS of $0.27 and revenue of $235.76M. Analysts’ consensus target is $89.89.

Original reporting
Published May 28, 2026, 1:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 28, 2026, 2:07 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Mercury Systems (NASDAQ:MRCY) Director Howard Lance Sells 9,250 Shares — source image
Decision brief

The 30-second read

$MRCYNeutralLow
01

Why it matters

Trading impact is likely sentiment-driven and secondary to fundamentals; without guidance changes, the disclosure mainly affects near-term positioning.

02

Market read

A director’s disclosed sale at ~$99.76 is a modest negative sentiment input, but the article lacks new operational catalysts.

03

What to watch

Recent May 5 results (EPS and revenue beat) and the stock’s proximity to the 12-month high may dominate price action versus a single director’s sale.

Relevance 6/10Timing: Immediate (today/next session) as traders digest the SEC disclosure; fades unless follow-on news emerges.

Background

The article summarizes an SEC-disclosed director sale and reiterates recent earnings performance plus analyst rating/target context.

Company-level read

Ticker impact

$MRCYNeutralMedium confidence
Context

Mercury Systems director Howard Lance sold 9,250 shares at an average $99.76, disclosed via SEC filing dated May 26.

Expected impact

Likely limited/short-lived impact; focus remains on the recent May 5 earnings beat and ongoing analyst target dispersion.

Evidence & confidence

The news is an ownership-change disclosure (Form 4-style) without accompanying guidance, contract, or regulatory developments; magnitude is modest versus company market cap.

Market effects

Minimal; this is company-specific insider activity with no sector-wide catalyst described.

Minimal; no geographic or cross-border operational change mentioned.

Minimal; no international deal/regulatory event cited.

Counterpoint

The sale could be routine diversification or planned liquidity rather than a bearish view, especially with no accompanying negative company update.

Key entities

  • Mercury Systems, Inc.

    Secure processing subsystems provider for aerospace/defense; subject of the director sale disclosure and recent earnings recap.

  • Howard Lance

    Director who sold 9,250 shares; transaction details provided (avg price $99.76; total $922,780).

Related articles

$MRCYMed

A Palantir Deal May Boost Mercury System’s Efficiency, But Don’t Rush to Buy MRCY Stock

Mercury Systems (MRCY) reported Q3 FY2026 revenue of $235.8M, up 11.5% YOY, above the $214.1M consensus. Non-GAAP EPS was $0.27 versus $0.06 expected. Total backlog rose to about $1.6B. Management raised FY adjusted EBITDA margin to mid-teens and expects mid-single-digit revenue growth, with positive free cash flow in Q4. The article cites a Palantir partnership and notes a $106.56 mean price target.

$RDDTMedAI 8/10

Dow tops 51,000 for first time as Wall Street caps record month

US stocks ended a record month higher on Friday, with the Dow Jones up 363 points (0.7%) to a record 51,032 for the first time above 51,000. The S&P 500 rose 0.2% to 7,580 and the Nasdaq gained 0.2% to 26,973, as AI optimism and easing Middle East risks supported sentiment ahead of Iran-related decisions and next week’s US jobs data.

$MRCYMedAI 9/10

Analysts Revise Price Targets on Mercury Systems, Inc. (MRCY) Following Q3 Earnings Report

Mercury Systems’ Q3 results led analysts to revise MRCY price targets in May. Goldman raised its target to $68 from $60 but kept a Sell rating. Jefferies lifted to $95 from $80 and maintained Hold after the company raised 2026 guidance; Canaccord increased to $106 and kept Buy. Q3 revenue was $236M (+11.5% organic), adjusted EPS $0.27, bookings $348M, backlog $1.6B.

$MRCYMedAI 8/10

Luca Re Ltd. (Series 2026-1)

Mercury General Corporation returned to the catastrophe bond market with its second 144A issuance via Luca Re Ltd. (Bermuda) to fund wildfire reinsurance. Luca Re offers $100m (Series 2026-1 Class A) to collateralize a reinsurance agreement covering Mercury’s California subsidiaries. The notes target ~3-year protection for wildfire and fire-following earthquake losses, with $1.75bn attachment and $2bn limit. Initial risk spread guidance is 6.25%-6.75%, with 1.23% attachment probability and 1.09%

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.